Live Chat ×
Skip to main content

Cases and Controversy in Glaucoma: Adventures in a Wonderland of Options

Description

Cases and Controversy in Glaucoma: Adventures in a Wonderland of Options

CME Symposium

Sunday, November 15, 2020
5:30 AM PST | 6:30 AM MST | 7:30 AM CST | 8:30 AM EST

Please click the REGISTER button on the right to register for this program. You will receive a confirmation email with a link to access the program. A reminder email closer to the date of the program will be sent as well.

If you would like to register for other AAO MedEdicus CME Programs: 
CLICK HERE

Please contact info@mededicus.com with any questions. Thank you!

FACULTY

Ike K. Ahmed, MD, FRCSC
Professor
University of Utah
Salt Lake City, Utah
Assistant Professor
Director, Glaucoma and Advanced Anterior Segment Surgery (GAASS) Fellowship
Research Director, Kensington Eye Institute
University of Toronto
Toronto, Canada

Sahar Bedrood, MD, PhD
Ophthalmologist
Acuity Eye Group
Adjunct Clinical Assistant Professor
USC Roski Eye Institute
Los Angeles County + USC Medical Center
Pasadena, California

E. Randy Craven, MD
Chief
Wilmer Eye Institute - Bethesda
Associate Professor of Ophthalmology
Johns Hopkins University School of Medicine
Bethesda, Maryland

Deborah Risveldt, DO
Ophthalmologist Surgeon
Vance Thompson Vision
Sioux Falls, South Dakota

CONTINUING MEDICAL EDUCATION INFORMATION

Learning Method and Medium
This educational activity consists of a CME symposium and ten (10) study questions. The participant should, in order, read the learning objectives, participate in the meeting, answer all questions in the post test, and complete the evaluation. To receive credit for this activity, please complete the post test and evaluation. This educational activity should take a maximum of 1.5 hours to complete.

Target Audience
This educational activity is intended for ophthalmologists caring for patients with glaucoma.

Learning Objectives
Upon completion of this activity, participants will be better able to:
  • Discuss safety and efficacy data for approved and emerging sustained drug delivery devices for glaucoma
  • Identify patients with glaucoma most likely to benefit from sustained drug delivery
  • Select appropriate MIGS procedures according to individual patient needs and characteristics

Accreditation Statement
The New York Eye and Ear Infirmary of Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This educational activity was developed and implemented in collaboration with MedEdicus LLC.

AMA Credit Designation Statement
The New York Eye and Ear Infirmary of Mount Sinai designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Grantor Statement
This continuing medical education activity is supported through an unrestricted educational grant from Allergan.

Disclosure Policy Statement
It is the policy of New York Eye and Ear Infirmary of Mount Sinai that the faculty and anyone in a position to control activity content disclose any real or apparent conflicts of interest relating to the topics of the educational activity in which they are participating. They are also required to disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentations. New York Eye and Ear Infirmary of Mount Sinai is committed to providing its learners with quality CME activities and related materials that promote improvements in healthcare and not the proprietary interests of a commercial interest and, thus, has established policies and procedures in place that identify and resolve all conflicts of interest prior to the execution or release of its educational activities. Full disclosure of faculty/planners and their commercial relationships, if any, follows.

Faculty
Ike K. Ahmed, MD, FRCSC, had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Aequus BioPharma, Inc; Aerie Pharmaceuticals, Inc; Akorn, Inc; Alcon; Allergan; ArcScan, Inc; Bausch & Lomb Incorporated; Beaver-Visitec International; Beyeonics Surgical Ltd; Camras Vision, Inc; Carl Zeiss Meditec, Inc; CorNeat Vision Ltd; Ellex; ELT Sight, Inc; ElutiMed; Equinox; Genentech, Inc; Glaukos Corporation; Injectsense, Inc; IRIDEX Corporation; iSTAR; Ivantis Inc; Johnson & Johnson Vision Care, Inc; Kelotec Inc; LayerBio, Inc; Leica Microsystems; Long Bridge Medical, Inc; MicroOptx; MicroSurgical Technology; Minosys Cellular Devices Inc; New World Medical, Inc; Ocular Instruments; Ocular Therapeutix, Inc; Omega Ophthalmics; Polyactiva Pty Ltd; Sanoculis Ltd; Santen Inc; ScienceBased Health; Sight Sciences; Smartlens, Inc; Strõma Medical Corporation; Thea Pharmaceuticals Limited; Vialase, Inc; Vizzario; and W. L. Gore & Associates, Inc; Contracted Research: Aerie Pharmaceuticals, Inc; Alcon; Allergan; Camras Vision, Inc; Glaukos Corporation; Ivantis Inc; Johnson & Johnson Vision Care, Inc; New World Medical, Inc; and Santen Inc; Honoraria from promotional, advertising or non-CME services received directly from commercial interests or their Agents (eg, Speakers Bureaus): Alcon; Allergan; Carl Zeiss Meditec, Inc; Johnson & Johnson Vision Care, Inc; MicroSurgical Technology; and Mundipharma International.

Sahar Bedrood, MD, PhD,
had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Allergan; Glaukos Corporation; and Santen Inc; Contracted Research: Allergan; Honoraria from promotional, advertising or non-CME services received directly from commercial interests or their Agents (eg, Speakers Bureaus): Allergan; and Glaukos Corporation.

E. Randy Craven, MD, had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Allergan; Ivantis Inc; Sight Sciences; and W. L. Gore & Associates, Inc; Contracted Research: Allergan; Sight Sciences; and W. L. Gore & Associates, Inc.

Debbie Risveldt, MD, had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant/Advisory Board: Sight Sciences; Contracted Research: Allergan. Honoraria from promotional, advertising or non-CME services received directly from commercial interests or their Agents (eg, Speakers Bureaus): Alcon; Allergan; Glaukos Corporation; and Sight Sciences. 

Editorial Support Disclosures
Erika Langsfeld, PhD; Cynthia Tornallyay, RD, MBA, CHCP; Barbara Aubel; and Michelle Ong have no relevant commercial relationships to disclose.

Disclosure Attestation
The contributing physicians listed above have attested to the following:
  1. that the relationships/affiliations noted will not bias or otherwise influence their involvement in this activity;
  2. that practice recommendations given relevant to the companies with whom they have relationships/affiliations will be supported by the best available evidence or, absent evidence, will be consistent with generally accepted medical practice; and
  3. that all reasonable clinical alternatives will be discussed when making practice recommendations.

Off-Label Discussion

This CME activity includes discussion of unlabeled and/or investigative uses of drugs and/or devices. Please refer to the official prescribing information for each drug or device discussed in this activity for FDA-approved dosing, indications, and warnings.

New York Eye and Ear Infirmary of Mount Sinai Privacy & Confidentiality Policies
https://www.nyee.edu/education/cme

CME Provider Contact Information
For questions about this activity, call 917-270-7571.

To Obtain AMA PRA Category 1 Credit
To obtain AMA PRA Category 1 Credit™ for this activity, participate in the meeting and complete the post test and evaluation. You may take the test up to 2 times. Upon registering and completing the post test, your certificate will be made available online and you can print it or file it.

Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of New York Eye and Ear Infirmary of Mount Sinai, MedEdicus LLC, or Allergan.

This CME activity is copyrighted to MedEdicus LLC © 2020. All rights reserved. 233

This CME symposium is not affiliated with the official program of AAO 2020.

November 15, 2020
Sun 8:30 AM EST

Duration 1H 30M

Already Registered?